SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
一辉
Lv7
5008 积分
2021-05-31 加入
最近求助
最近应助
互助留言
Good response of cadonilimab (PD-1/CTLA-4 Bi-specific antibody) to patients with advanced lung adenocarcinoma after immunotherapy resistance: A case report
12天前
已完结
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
30天前
已完结
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies
30天前
已完结
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study
1个月前
已完结
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
1个月前
已完结
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer
1个月前
已完结
Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study
2个月前
已关闭
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2个月前
已完结
Sacituzumab govitecan: past, present and future of a new antibody–drug conjugate and future horizon
3个月前
已完结
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
4个月前
已完结
没有进行任何应助
感谢
12天前
感谢
30天前
感谢
30天前
感谢
1个月前
下的附件,非正文
1个月前
感谢
1个月前
感谢
1个月前
已下载到文献【积分已退回】
2个月前
感谢
2个月前
感谢
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论